Skip to main content
IRIX logo

IRIDEX Corporation

IRIXNASDAQHealthcareMedical Devices

$0.75Today:- (-)1Y −30.06%

As of Oct 26, 2026 close

Market cap
$13.13M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.61$1.65
Volume (live)
-
Avg. volume (3M)
742.59K

IRIDEX (IRIX) Cash Flow Statement

In fiscal 2026 (fiscal year ended Jan 3, 2026), IRIDEX used $2.12M of cash in operating activities and spent $143.00K on capital expenditures. That left free cash flow of −$2.26M. It repurchased $75.00K of its own shares.

IRIDEX Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for IRIDEX Corporation (IRIX) - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2020FY 2019FY 2018FY 2017
Period endingJan 2026Dec 2025Dec 2024Dec 2023Dec 2022Jan 2022Dec 2021Jan 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-4.44-4.44-8.91-9.57-7.55-5.23-5.23-6.33-6.33-8.81-12.81-12.87
Depreciation & Amortization0.521.551.422.030.490.801.710.500.500.690.810.86
Deferred Income Tax-0.000.000.000.00-0.00-0.000.000.00-0.14
Stock Based Compensation0.780.781.241.651.621.631.631.121.121.701.801.92
Change in Working Capital--2.39-1.37-0.86-5.1612.5612.561.271.27-1.570.026.40
Change in Accounts Receivable-1.15-1.151.260.36-0.24-2.47-2.471.861.86-0.27-1.162.16
Change in Inventory2.122.12-0.910.64-3.020.270.272.382.380.550.462.09
Change in Accounts Payable-2.45-1.952.870.640.472.251.63-1.45-1.450.080.79-0.27
Change in Other Working Capital-0.14-1.400.33-2.50-2.60-1.2813.14-0.94-1.53-1.92-0.072.42
Other Operating Activities3.412.390.330.001.09-1.55-2.46-0.200.070.150.26
Net Cash from Operating Activities-2.12-2.12-7.29-6.75-9.528.228.22-3.24-3.24-7.91-10.03-3.57
Investing Activities
Capital Expenditures-0.14-0.14-0.01-0.11-0.29-0.21-0.21-0.10-0.10-0.13-0.44-0.58
Acquisitions-0.000.000.000.00-5.34-5.34-0.000.00-0.39-0.38
Other Investing Activities-0.000.000.000.00-0.00-0.00-0.38-0.39-0.21
Net Cash from Investing Activities-0.14-0.14-0.01-0.11-0.29-5.56-5.56-0.09-0.09-0.51-0.83-0.78
Financing Activities
Debt Repayment3.960.04-0.220.000.00-0.00-2.500.000.000.00
Common Stock Issued-6.003.370.080.0210.109.88-0.000.0010.482.26
Common Stock Repurchased0.080.000.000.000.090.630.00-0.030.000.000.000.00
Other Financing Activities--0.08-0.55-0.09-0.09--0.41--0.03-0.16-0.100.04
Net Cash from Financing Activities5.965.962.610.00-0.079.479.472.472.47-0.1610.382.31
Summary
Effect of Forex Changes on Cash-0.07-0.070.05-0.03-0.050.100.10--0.160.04-0.040.00
Net Change in Cash3.643.64-4.65-6.89-9.9312.2312.23-1.03-1.03-8.54-0.51-2.04
Cash at Beginning of Period-2.397.0313.9223.85-11.63-12.6521.1921.7123.75
Cash at End of Period-6.032.397.0313.92-23.85-11.6312.6521.1921.71
Free Cash Flow-2.26-2.26-7.30-6.85-9.818.008.00-3.33-3.33-8.04-10.47-4.14
Supplemental Disclosures
Income Taxes Paid--0.020.050.070.02--0.07----

Source: Company financial statements from annual and quarterly filings. Data as of Jul 4, 2026. Data sources and methodology

Frequently Asked Questions About IRIDEX Cash Flow

What is IRIDEX's free cash flow?

IRIDEX had negative free cash flow of $2.26M in fiscal 2026 (fiscal year ended Jan 3, 2026), operating cash flow of −$2.12M minus $143.00K of capital expenditures.

How much does IRIDEX spend on capital expenditures?

IRIDEX spent $143.00K on capital expenditures in fiscal 2026, compared with $143.00K a year earlier.

Does IRIDEX pay dividends or buy back shares?

Yes. In fiscal 2026 IRIDEX returned $75.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition